Knowledge-guided Docking: Accurate Prospective Prediction of Bound Configurations of Novel Ligands Using Surflex-Dock
Overview
Molecular Biology
Authors
Affiliations
Prediction of the bound configuration of small-molecule ligands that differ substantially from the cognate ligand of a protein co-crystal structure is much more challenging than re-docking the cognate ligand. Success rates for cross-docking in the range of 20-30 % are common. We present an approach that uses structural information known prior to a particular cutoff-date to make predictions on ligands whose bounds structures were determined later. The knowledge-guided docking protocol was tested on a set of ten protein targets using a total of 949 ligands. The benchmark data set, called PINC ("PINC Is Not Cognate"), is publicly available. Protein pocket similarity was used to choose representative structures for ensemble-docking. The docking protocol made use of known ligand poses prior to the cutoff-date, both to help guide the configurational search and to adjust the rank of predicted poses. Overall, the top-scoring pose family was correct over 60 % of the time, with the top-two pose families approaching a 75 % success rate. Correct poses among all those predicted were identified nearly 90 % of the time. The largest improvements came from the use of molecular similarity to improve ligand pose rankings and the strategy for identifying representative protein structures. With the exception of a single outlier target, the knowledge-guided docking protocol produced results matching the quality of cognate-ligand re-docking, but it did so on a very challenging temporally-segregated cross-docking benchmark.
Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands.
Cleves A, Tandon H, Jain A J Comput Aided Mol Des. 2024; 38(1):33.
PMID: 39414633 PMC: 11485047. DOI: 10.1007/s10822-024-00574-0.
Bridging Structure- and Ligand-Based Virtual Screening through Fragmented Interaction Fingerprint.
Syahdi R, Jasial S, Maeda I, Miyao T ACS Omega. 2024; 9(37):38957-38969.
PMID: 39310180 PMC: 11411525. DOI: 10.1021/acsomega.4c05433.
Tian Y, Tong J, Liu Y, Tian Y Molecules. 2024; 29(8).
PMID: 38675594 PMC: 11052498. DOI: 10.3390/molecules29081772.
Al Neyadi S, Adem A, Amir N, Ghattas M, Abdou I, Salem A ACS Omega. 2024; 9(5):5463-5484.
PMID: 38343951 PMC: 10851269. DOI: 10.1021/acsomega.3c07149.
Cosolvent Sites-Based Discovery of Protein Kinase G Inhibitors.
Burastero O, Defelipe L, Gola G, Tateosian N, Lopez E, Martinena C J Med Chem. 2022; 65(14):9691-9705.
PMID: 35737472 PMC: 9344462. DOI: 10.1021/acs.jmedchem.1c02012.